MARKET

NPCE

NPCE

Neuropace Inc
NASDAQ
13.92
-0.14
-1.00%
Opening 10:03 09/28 EDT
OPEN
14.01
PREV CLOSE
14.06
HIGH
14.14
LOW
13.83
VOLUME
13.60K
TURNOVER
--
52 WEEK HIGH
19.60
52 WEEK LOW
9.22
MARKET CAP
477.79M
P/E (TTM)
-24.5330
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NPCE last week (0921-0925)?
Weekly Report · 4h ago
Weekly Report: what happened at NPCE last week (0914-0918)?
Weekly Report · 09/21 09:16
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga · 09/18 11:53
NeuroPace Price Target Announced at $18.00/Share by Keybanc
Dow Jones · 09/18 10:47
Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18
Benzinga · 09/18 10:38
NeuroPace initiated with an Overweight at KeyBanc
TipRanks · 09/18 09:15
Weekly Report: what happened at NPCE last week (0907-0911)?
Weekly Report · 09/14 09:17
Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?
NASDAQ · 09/10 15:30
More
About NPCE
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.

Webull offers Neuropace Inc stock information, including NASDAQ: NPCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NPCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NPCE stock methods without spending real money on the virtual paper trading platform.